Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 14

Zeitschriftenartikel

Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2022): Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. In: Investigational new drugs, Bd. 40: S. 163-171 [PDF, 1MB]

Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2022): Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276 [PDF, 1MB]

Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Rühle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad (2021): Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. In: Investigational new drugs, Bd. 39: S. 1189-1196 [PDF, 586kB]

Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Ruehle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. In: Investigational New Drugs, Bd. 39, Nr. 4: S. 1189-1196

Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting. In: Cancers, Bd. 13, Nr. 7, 1613

Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171

Multhoff, Gabriele; Seier, Sophie; Stangl, Stefan; Sievert, Wolfgang; Shevtsov, Maxim; Werner, Caroline; Pockley, A. Graham; Blankenstein, Christiane; Hildebrandt, Martin; Offner, Robert; Ahrens, Norbert; Kokowski, Konrad; Hautmann, Matthias; Roedel, Claus; Fietkau, Rainer; Lubgan, Dorota; Huber, Rudolf; Hautmann, Hubert; Duell, Thomas; Molls, Michael; Specht, Hanno; Haller, Bernhard; Devecka, Michal; Sauter, Andreas und Combs, Stephanie E. (2020): Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial. In: Clinical Cancer Research, Bd. 26, Nr. 20: S. 5368-5379

Biehl, Wiebke; Hattesohl, Akira; Joerres, Rudolf A.; Duell, Thomas; Althoehn, Ulrike; Koczulla, Andreas Rembert und Schmetzer, Helga (2019): VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials. In: Acta Oncologica

Klotz, Laura; Lindner, Michael; Eichhorn, Martin E.; Gruetzner, Uwe; Koch, Ina; Winter, Hauke; Kauke, Teresa; Duell, Thomas und Hatz, Rudolf A. (2019): Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma. In: Journal of Thoracic Disease, Bd. 11, Nr. 5: S. 1963-1972

Tufman, Amanda; Duell, Thomas und Schneider, Christian (2019): Die Nachsorge des Lungenkarzinoms. In: Zentralblatt für Chirurgie, Bd. 144, Nr. 1: S. 106-117

Tufman, Amanda; Kahnert, Kathrin; Duell, Thomas; Kauffmann-Guerrero, Diego; Milger, Katrin; Schneider, Christian; Stump, Julia; Syunyaeva, Zulfiya; Huber, Rudolf Maria und Reu, Simone (2017): Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer. In: Oncotargets and therapy, Bd. 10: S. 5179-5186 [PDF, 535kB]

Specht, Hanno M.; Ahrens, Norbert; Blankenstein, Christiane; Duell, Thomas; Fietkau, Rainer; Gaipl, Udo S.; Günther, Christine; Gunther, Sophie; Habl, Gregor; Hautmann, Hubert; Hautmann, Matthias; Huber, Rudolf Maria; Molls, Michael; Offner, Robert; Rödel, Claus; Rödel, Franz; Schütz, Martin; Combs, Stephanie E. und Multhoff, Gabriele (2015): Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial. In: Frontiers in Immunology, Bd. 6, UNSP 162 [PDF, 812kB]

Pawel, Joachim; Wagner, Horst; Duell, Thomas und Poellinger, Barbara (2008): Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: Two case reports. In: Onkologie, Nr. 3: S. 123-126 [PDF, 165kB]

Duell, Thomas; Poleck-Dehlin, Brigitte; Schmid, Christoph; Wunderlich, Bettina; Ledderose, Georg; Mittermueller, Johann; Kolb, Hans Jochem und Schmetzer, Helga Maria (2006): Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia. In: Acta Haematologica, Nr. 2: S. 131-136 [PDF, 141kB]

Diese Liste wurde am Sat Mar 23 21:53:18 2024 CET erstellt.